You Want Those Genes CRISPR’d?

TitleYou Want Those Genes CRISPR’d?
Publication TypeCase Study
Year of Publication2018
AuthorsSkipper, RB, Currie, RA, Jones, C, Pease, H, McNichol, J
Date Published12/2018
PublisherAssociation for Practical and Professional Ethics
Publication LanguageEnglish
AbstractCRISPR-Cas9 is a gene correction system that is simpler to design, easier to use, less time consuming and less costly than previous techniques. Applications of the technology are so broad "that the possibilities for using it to treat disease are virtually endless," according to E. Mullin at the MIT Technology Review. Researchers across the globe are exploring the uses of CRISPR-Cas9. The Chinese ministry of health has approved all gene-therapy clinical trials in China. According to the Wall Street Journal's article, "China, Unhampered by Rules, Races Ahead in Gene-Editing Trials," so far, "scientists have genetically engineered the cells of at least 86 cancer and HIV patients in the country using CRISPER- Cas9 technology since 2015."
NotesCase from the 2019 National Intercollegiate Ethics Bowl     Licensed undertheCreativeCommons Attribution-NonCommercial-NoDerivatives 4.0 InternationalLicense.To viewa copyofthislicense,visithttp://creativecommons.org/licenses/by- nc-nd/4.0/.©2017 RobertSkipper,RobertA.Currie,CynthiaJones,HeatherPease,and Jane McNichol.
URLhttp://ethics.iit.edu/EEL/CRISPR.pdf

Discipline: 

Subject: 

Publication: